| Nov 15, 2024 |
Nov 19, 2024 |
RECURSION PHARMACEUTICALS, INC.
|
Chief Medical Officer |
Sell |
46.3
|
-4,187
|
-1.82%
|
✗
|
$25.9K |
| Aug 15, 2024 |
Aug 19, 2024 |
RECURSION PHARMACEUTICALS, INC.
|
Chief Medical Officer |
Sell |
42.5
|
-14,146
|
-5.80%
|
✗
|
$94.6K |
| May 15, 2024 |
May 17, 2024 |
RECURSION PHARMACEUTICALS, INC.
|
Chief Medical Officer |
Sell |
52.5
|
-867
|
-0.35%
|
✗
|
$8.7K |
| Feb 9, 2024 |
Feb 13, 2024 |
RECURSION PHARMACEUTICALS, INC.
|
Chief Medical Officer |
Sell |
91.3
|
+53,916
|
28.27%
|
✗
|
$19.1K |
| Oct 5, 2021 |
Oct 6, 2021 |
Prelude Therapeutics Inc
|
Chief Medical Officer |
Sell |
7.5
|
-15,000
|
-100.00%
|
✓
|
$464.3K |
| Sep 7, 2021 |
Sep 9, 2021 |
Prelude Therapeutics Inc
|
Chief Medical Officer |
Sell |
7.5
|
-15,000
|
-100.00%
|
✓
|
$550.3K |
| Aug 5, 2021 |
Aug 9, 2021 |
Prelude Therapeutics Inc
|
Chief Medical Officer |
Sell |
7.5
|
-15,000
|
-100.00%
|
✓
|
$466.4K |
| Jul 6, 2021 |
Jul 8, 2021 |
Prelude Therapeutics Inc
|
Chief Medical Officer |
Sell |
7.5
|
-15,000
|
-100.00%
|
✓
|
$412.1K |
| Jun 7, 2021 |
Jun 9, 2021 |
Prelude Therapeutics Inc
|
Chief Medical Officer |
Sell |
7.5
|
-15,000
|
-100.00%
|
✓
|
$486.6K |
| May 5, 2021 |
May 10, 2021 |
Prelude Therapeutics Inc
|
Chief Medical Officer |
Sell |
7.5
|
-15,000
|
-100.00%
|
✓
|
$602.1K |
| Apr 27, 2021 |
Apr 29, 2021 |
Prelude Therapeutics Inc
|
Chief Medical Officer |
Sell |
7.5
|
-25,000
|
-100.00%
|
✓
|
$884.8K |
| Apr 19, 2021 |
Apr 21, 2021 |
Prelude Therapeutics Inc
|
Chief Medical Officer |
Sell |
7.5
|
-25,000
|
-100.00%
|
✓
|
$772.3K |
| Apr 8, 2021 |
Apr 15, 2021 |
Prelude Therapeutics Inc
|
Chief Medical Officer |
Sell |
7.5
|
-9,617
|
-100.00%
|
✓
|
$368.9K |
| Apr 7, 2021 |
Apr 9, 2021 |
Prelude Therapeutics Inc
|
Chief Medical Officer |
Sell |
7.5
|
-15,383
|
-100.00%
|
✓
|
$605K |